Surgery Partners, Inc. Common Stock

SGRY

Surgery Partners, Inc. (SGRY) is a healthcare company that provides outpatient surgical services through a network of surgical facilities across the United States. The company focuses on delivering specialized procedures in areas such as outpatient surgery, endoscopy, pain management, and other ambulatory care services, aiming to improve patient outcomes and streamline healthcare delivery.

$15.77 -0.03 (-0.19%)
🚫 Surgery Partners, Inc. Common Stock does not pay dividends

Company News

Surgery Partners, Inc. Announces Pricing of Add-On Notes Offering
GlobeNewswire Inc. • Surgery Partners, Inc. • December 11, 2025

Surgery Partners priced $425 million in senior unsecured notes due 2032, intending to use proceeds for general corporate purposes including repaying outstanding borrowings under its revolving credit facility.

AirSculpt Technologies Appoints Mike Doyle as Non-Executive Chairman of the Board
GlobeNewswire Inc. • Yogi Jashnani • November 17, 2025

AirSculpt Technologies appointed Mike Doyle as Non-Executive Chairman of its Board of Directors. Doyle brings over 30 years of leadership experience in multi-center healthcare and has previously led Surgery Partners and founded MD Healthcare Partners.

Why Surgery Partners Stock Plummeted on Monday
The Motley Fool • Eric Volkman • November 10, 2025

Surgery Partners experienced a significant stock drop of nearly 25% after reporting Q3 earnings that missed analyst expectations, with lower-than-anticipated non-GAAP earnings and revenue, despite a 7% year-over-year revenue growth.

Surgery Partners, Inc. Announces Third Quarter 2025 Earnings Release Date and Conference Call Details
GlobeNewswire Inc. • Surgery Partners Investor Relations • October 24, 2025

Surgery Partners will release its Q3 2025 financial results on November 10, 2025, before market opening, followed by a conference call at 8:30 a.m. Eastern Time.

Surgery Partners (SGRY) Q2 Revenue Up 8%
The Motley Fool • Jesterai • August 6, 2025

Surgery Partners reported Q2 2025 revenue of $826.2 million, an 8.4% year-over-year increase, with mixed financial results. The company saw strong case volume growth and reaffirmed full-year guidance, despite challenges with net losses and higher network growth costs.

Related Companies